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Upon infection, antigen-specific naive CD8 T cells
are activated and differentiate into short-lived
effector cells (SLECs) and memory precursor cells
(MPECs). The underlying signaling pathways remain
largely unresolved. We show that Rictor, the core
component of mammalian target of rapamycin com-
plex 2 (mTORC2), regulates SLEC and MPEC
commitment. Rictor deficiency favors memory for-
mation and increases IL-2 secretion capacity
without dampening effector functions. Moreover,
mTORC2-deficient memory T cells mount more
potent recall responses. Enhanced memory forma-
tion in the absence of mTORC2 was associated
with Eomes and Tcf-1 upregulation, repression of
T-bet, enhanced mitochondrial spare respiratory
capacity, and fatty acid oxidation. This transcrip-
tional and metabolic reprogramming is mainly
driven by nuclear stabilization of Foxo1. Silencing
of Foxo1 reversed the increased MPEC differentia-
tion and IL-2 production and led to an impaired
recall response of Rictor KO memory T cells. There-
fore, mTORC2 is a critical regulator of CD8 T cell dif-
ferentiation and may be an important target for
immunotherapy interventions.INTRODUCTION
CD8 T cells play a crucial role in immunity to infection and can-
cer (Chang et al., 2014; Dudda et al., 2013; Kaech and Cui,
2012). Following an acute bacterial or viral infection, naive
CD8 T cells are instructed by antigens, co-stimulatory mole-
cules, and cytokines to undergo clonal expansion and functional
differentiation into effector or memory T cells. Killer cell lectin-1206 Cell Reports 14, 1206–1217, February 9, 2016 ª2016 The Autholike receptor G1 (KLRG1) and interleukin 7 receptor a (IL-7Ra,
CD127) surface markers discriminate short-lived effector cells
(SLECs) from memory precursor effector cells (MPECs) (Chang
et al., 2014; Kaech and Cui, 2012; Kaech et al., 2003; Sallusto
et al., 1999; Wherry et al., 2003). The decision process is
affected by inflammation, which triggers distinct transcriptional
programs in primed CD8 T cells (Joshi et al., 2007). Multiple
transcription factors have been identified to control CD8
effector or memory differentiation (Bo¨ttcher and Knolle, 2015;
Chang et al., 2014; Kaech and Cui, 2012). The T box transcrip-
tion factors T-bet and Eomesodermin (Eomes) represent two
key transcription factors in orchestrating the SLEC or MPEC
fate decision (Chang et al., 2014; Joshi et al., 2007; Kaech
and Cui, 2012). In addition, B lymphocyte-induced maturation
protein 1 (Blimp-1) and B cell lymphoma 6 (Bcl-6) are reciprocal
regulators of CD8 effector and memory differentiation. Blimp-1
enhances the formation of terminally differentiated effectors
by directly binding to Bcl-6 to repress its expression (Ji et al.,
2011; Kallies et al., 2009; Rutishauser et al., 2009). Moreover,
Id2- or Id3-deficient mice fail to generate short-lived effector
or long-lived memory cells, respectively (Ji et al., 2011; Yang
et al., 2011). However, the T cell intrinsic signaling pathways
controlling cell fate decision between SLECs and MPECs
remain poorly understood.
Mammalian target of rapamycin (mTOR) is an evolutionarily
conserved serine/threonine kinase that integrates multiple envi-
ronmental cues to regulate cell growth, proliferation, and meta-
bolism (Betz and Hall, 2013; Shimobayashi and Hall, 2014). In
mammalian cells, mTOR can form functionally distinct mTOR
complex 1 (mTORC1) andmTOR complex 2 (mTORC2)multipro-
tein complexes. Raptor and Rictor are the core adaptor compo-
nents of mTORC1 and mTORC2, respectively (Betz and Hall,
2013), whose deletion leads to loss of mTORC1 or mTORC2
integrity and activity (Bentzinger et al., 2008). mTORC1 has
been shown to regulate both innate and adaptive immunity
(Chen et al., 2013; Chi, 2012; Delgoffe et al., 2009; Powell
et al., 2012; Waickman and Powell, 2012; Zhu et al., 2014). In
T cells, mTORC1 integrates the signals from the T cell receptorrs
Figure 1. Rictor-Deficient CD8 T Cells
Mount Effective Effector Responses to
Infection
(A) Schematic of LM-OVA infection. 10, 000 WT or
Rictor KO naive OT-1 cells were transferred into
naive CD45.1 recipients, followed by injection of
2,000 CFUs of LM-OVA N4 or T4 i.v.
(B) Flow cytometry analysis of CD8 and CD45.2
cells in the spleen and pLNs.
(C) The percentages and absolute numbers of
transferred WT or Rictor KO OT-1 cells harvested
in the spleen (top) and pLNs (bottom) were quan-
tified after N4 infection.
(D) In vitro killing assay with Cr51 release or sorted
WT or Rictor KO effector OT-1 cells on day 7 after
infection were incubated with SIINFEKL peptide-
pulsed (left) or -non-pulsed (right) EL-4 target cells
at different ratios.
(E–G) Representative overlay histograms and the
mean fluorescence intensity (MFI) of granzyme B
(E), perforin (F), or CD107a (G) expression on
transferred WT or Rictor KO OT-1 cells on day 7
after LM-OVA N4 infection. In (E) and (F), the
shaded gray histograms represent background
levels in gated CD4 T cells. For CD107a, the
shaded gray histogram represents WT OT-1 cells
without SIINFEKL peptide stimulation.
Data are representative of three or four indepen-
dent experiments and are presented as the mean
± SEM (4–6 mice/group). **p < 0.01; ***p < 0.001;
ns, not significant. See also Figure S1.(TCR), co-stimulation, cytokines, and nutrients to regulate cell
proliferation and differentiation (Zhang et al., 2012). Indeed,
mTORC1 is required for Th1, Th2, Th17, and invariant natural
killer T (iNKT) cell differentiation (Delgoffe et al., 2009, 2011;
Shin et al., 2014; Yang et al., 2013; Zhang et al., 2014). Interest-
ingly, pharmacological inhibition of mTORC1 by rapamycin in
acutely Lymphocytic choriomeningitis virus (LCMV)-infected
mice leads to increased magnitude and qualities of memory
CD8 T cell differentiation (Araki et al., 2009; Pearce et al.,
2009). Consistently, deletion of TSC1 or TSC2, the upstream in-
hibitor of mTORC1, drives stronger effector responses but im-
pairs memory formation (Krishna et al., 2014; Shrestha et al.,
2014). Recently, the Rictor containing mTORC2 or its down-
stream target serum- and glucocorticoid-regulated kinase
(SGK1) have been shown to promote Th2 differentiation (Del-Cell Reports 14, 1206–1217,goffe et al., 2011; Heikamp et al., 2014).
However, the role mTORC2 may have in
shaping CD8 T cell effector and memory
generation remains unknown.
RESULTS
Rictor-Deficient CD8 T Cells Mount
Effective Effector Responses
To investigate the role of mTORC2 in
shaping CD8 effector and memory dif-
ferentiation, we crossed Rictor knockout
(KO) mice onto an OT-1 backgroundand tested how Rictor deficiency would affect the CD8
response to Listeria monocytogenes ovalbumin (LM-OVA)
infection. Using this system, Zehn et al. (2009) showed that
the strength of TCR-ligand interaction critically affects CD8
T cell expansion, contraction, and migration. Therefore, we
transferred equal numbers of WT (Rictorflox/flox: CD4-Cre) or
Rictor KO (Rictorflox/flox: CD4-Cre+) OT-1 cells separately into
naive hosts that were then infected with LM recombinants en-
coding the natural ligand SIINFEKL (N4) or one altered peptide
ligand, SIITFEKL (T4), with about 100-fold lower functional avid-
ity for the OT-1 TCR (Zehn et al., 2009; Figure 1A). A similar
engraftment efficiency of transferred WT and Rictor KO OT-1
cells was confirmed 1 day later, before LM-OVA infection
(data not shown). On day 7 after infection, Rictor KO OT-1 cells
showed a 2-fold reduced frequency and absolute number ofFebruary 9, 2016 ª2016 The Authors 1207
Figure 2. Rictor Deficiency Leads to
Enhanced MPEC Generation while
Reducing SLECs.
(A) Representative FACS plots showing KLRG1,
CD127, CD27, CD62L, CD44, and CXCR3 staining
patterns on gated transferred OT-1 cells in the
spleen on day 7 after LM-OVA N4 infection.
(B and C) The frequencies (B) and absolute
numbers (C) of KLRG1hi CD127lo, KLRG1lo
CD127hi, and CD62L+CD44+ on gated transferred
OT-1 cells in the spleen are summarized.
(D) Intracellular Bcl-2 expression was determined
by flow cytometry.
(E) The MFI of Bcl-2 was determined in the spleen
(left) and pLN (right).
Data are representative of three or four indepen-
dent experiments and are presented as the mean
± SEM (4–6 mice/ group). *p < 0.05, **p < 0.01,
***p < 0.001. See also Figure S2.effector cells compared with the wild-type (WT) in response to
either N4 or T4 stimulation in the spleen, liver, lung, and bone
marrow (Figures 1B, 1C, and S1AS1C; data not shown).
However, the levels of transferred CD8 T cells in the periph-
eral lymph node (pLN) were comparable, suggesting that
T cell trafficking might also be regulated by mTORC2 (Figures
1B and 1C). To determine whether the reduced CD8 T cell
response in the absence of Rictor was due to decreased pro-
liferation or increased apoptosis, we first measured Ki67
expression on day 5 after infection. As expected, N4 infection
triggered higher Ki67 expression than T4, confirming the
higher expansion capacity upon strong ligand stimulation (Fig-
ure S1D). Consistent with the reduced CD8 T cell levels, Ki67
expression in Rictor KO OT-1 cells was reduced compared
with WT OT-1 cells after N4 infection (Figure S1D). In contrast,
Rictor deficiency did not detectably affect the apoptosis rate
of effector CD8 T cells (Figure S1E). These data suggest
that mTORC2 is required for CD8 sustained proliferation and
accumulation.
Next we examined whether Rictor-deficient CD8 T cells
were capable of killing antigenic target cells. We found that1208 Cell Reports 14, 1206–1217, February 9, 2016 ª2016 The AuthorsRictor KO effector cells could kill target
EL-4 cells pulsed with SIINFEKL pep-
tide as efficiently as WT effectors (Fig-
ure 1D). Granzyme B and perforin are
the key effector molecules responsible
for direct cytotoxicity of CD8 T cells.
In line with comparable killing ability
in vitro, both WT and Rictor KO effector
cells expressed similar high levels of
granzyme B and perforin (Figures 1E
and 1F). Furthermore, CD107a expres-
sion, a degranulation marker correlated
with cytolytic capacity, was strongly
upregulated at the surface membrane
of Rictor KO effector cells upon
in vitro peptide restimulation (Figure 1G).
Together, our data suggest that acqui-sition of CD8 T cell effector function is independent of
mTORC2.
Rictor Deficiency Leads to Enhanced MPEC Generation
while Reducing SLECs
Upon infection, antigen-primed CD8 T cells undergo differentia-
tion into SLECs and MPECs. SLECs, defined as KLRG1hi
CD127lo, undergo massive apoptosis during the contraction
phase after the infection clears, whereas KLRG1lo CD127hi
MPECs show increased potential to differentiate further into
long-lived memory lineage cells. To examine whether mTORC2
regulates SLEC and MPEC commitment, we determined the
expression profiles of KLRG1, CD127, and CD27 onWT or Rictor
KO effector OT-1 cells at the peak of the response to primary
infection. We found a significant reduction of KLRG1hi CD127lo
SLECs in the absence of Rictor (Figures 2A and 2B). Conversely,
the levels of KLRG1lo CD127hi MPECs were 2- to 3-fold higher in
Rictor KO than in WT responding cells (Figures 2A–2C). Consis-
tently, we also found increased percentages of the KLRG1lo
CD27+ population in the absence of Rictor (Figure 2A). Strikingly,
we observed a marked increase (more than 10-fold) in the
Figure 3. Rictor Deficiency Promotes Cell-
Autonomous IL-2 Production in CD8 T Cells.
(A and B) On day 7 after LM-OVA infection, sple-
nocytes from CD45.1 recipients transferred with
WT or Rictor KO OT-1 cells were isolated and re-
stimulated without (A) or with (B) the SIINFEKL
peptide for IFNg, TNF-a and IL-2.
(C and D) The frequencies of IFNg+TNF-a+ and
IFNg+IL-2+OT-1cells in thespleen (C) andpLNs (D).
(E–H)WTCD45.1/2+ naiveOT-1 cellsweremixed at
a 1:1 ratio with naiveWTCD45.2+ OT-1 cells (E and
G) or Rictor KO CD45.2+ OT-1 cells (F and H) and
transferred into CD45.1+ recipients, followed by
LM-OVAN4 infection 1 day later. Onday7 after LM-
OVA infection, splenocytes were re-stimulated with
the SIINFEKL peptide for IFNg, TNF-a, and IL-2.
Data are representativeof threeor four independent
experiments and are presented as themean ± SEM
(4–5 mice/group). **p < 0.01. See also Figure S3.frequency of Rictor KO OT-1 cells with the CD62L+ CD44+ cen-
tral memory phenotype, whereas WT OT-1 cells rarely harbor
this phenotype at this early time point after infection (Figures
2A–2C). Additionally, the percentages of CD127+ CXCR3+ cells
were also enhanced in the absence of mTORC2 (Figure 2A).
We also found a much higher intensity of CD62L, CD127, and
CD122 expression on a per-cell basis in the absence ofmTORC2
(Figure 2A; data not shown), indicating the potential for Rictor KO
cells to respond better to IL-7 or IL-15 stimulation. The increased
expression of CD62L and CCR7 was also confirmed at the tran-
scriptional level (Figure S2A). It has been shown that Bcl-2
expression is higher in MPECs that will differentiate further into
a long-lived memory lineage. Indeed, we found that Bcl-2
expression was much higher in Rictor KO CD8 T cells than that
of WT counterparts (Figures 2D and 2E).Cell Reports 14, 1206–1217,To exclude any effects from the inflam-
matory microenvironments in different
hosts, we adoptively co-transferred mix-
tures of WT CD45.1/2+ OT-1 cells with
Rictor KO CD45.2+ OT-1 cells at a 1:1 ra-
tio into the same host. Even in this setting,
higher MPEC and reduced SLEC fre-
quencies were observed in both the
spleen and pLNs (Figures S2B and S2C;
data not shown). The increased propor-
tions of the Rictor-deficient KLRG1lo
CD127hi or CD62L+ CD44+ populations
were even more striking in the host pLN
(data not shown). Taken together, these
findings support a CD8 T cell-intrinsic
role of mTORC2 in promoting MPEC
while inhibiting SLEC differentiation.
Rictor Deficiency Leads to
Enhanced Cell-Autonomous IL-2
Production in CD8 T Cells
At the peak of the primary T cell response
to acute infection, only a small fraction ofeffector CD8 T cells is able to produce IL-2 (Joshi et al., 2007;
Sarkar et al., 2008). On day 7 after LM-OVA N4 infection, about
15% of WT effector CD8 T cells secreted IL-2 (Figures 3A–3D).
Most intriguingly, we found a remarkably increased frequency
of IL-2-producing, Rictor-deficient CD8 T cells (Figures 3B–
3D). In contrast, they produced similar amounts of interferon g
(IFNg) and tumor necrosis factor a (TNF-a) in response to Ova-
N4 peptide stimulation as WT CD8 T cells (Figures 3C and 3D).
Moreover, we found that IL-2 production was also increased
significantly in Rictor KO effector cells in response to LM-OVA
T4 infection (Figure S3). Similarly, we reproduced the finding
that Rictor KO effectors from LM-OVA N4 infection produced
higher levels of IL-2 evenwith in vitro OVA-T4 peptide stimulation
(Figure S3). Moreover, higher IL-2 production was also observed
in Rictor KO effectors from LM-OVA T4 infection in the presenceFebruary 9, 2016 ª2016 The Authors 1209
Figure 4. Rictor Deficiency Leads to
Enhanced CD8 Memory T Cell Formation
and Better Recall Responses.
(A) Kinetic analysis of the frequency of
CD62L+CD44+ or KLRGlo CD127hi on transferred
WT or Rictor KO CD45.2 OT-1 cells at different
time points after N4 infection.
(B) Representative FACS plots showing the CD8
and CD45.2 staining patterns 7 weeks after
infection in the spleen and pLNs, gated on CD8
T cells.
(C) The absolute numbers of transferred WT or
Rictor KOCD45.2 OT-1 cells in the spleen (left) and
pLN (right).
(D) The absolute numbers of transferred WT or
Rictor KO CD45.2 OT-1 cells in the liver (left) and
lung (right).
(E) Representative FACS plots showing the
expression pattern of CD27, CD44, CD62L, and
CD127 on transferred WT or Rictor KO OT-1 cells
in the spleen.
(F) Representative FACS plots showing CD8 and
CD45.2 cells on day 4 after antigen re-exposure in
the spleen.
(G) Absolute number or fold expansion of WT or
Rictor KO OT-1 cells after re-challenge in the
spleen.
(H) In vitro Cr51 release-based killing assay with
sorted WT or Rictor KO effector OT-1 cells on day
4 after re-challenge, incubated with SIINFEKL
peptide-pulsed EL-4 target cells at different ratios.
(I) On day 4 after re-challenge, splenocytes from
CD45.1 recipients were isolated and re-stimulated
with the SIINFEKL peptide for intracellular staining
of IFNg and TNF-a.
Data are representative of two or three indepen-
dent experiments and are presented as themean ±
SEM (4–5 mice/group). *p < 0.05, **p < 0.01. See
also Figures S3 and S4.of OVA-N4 peptide stimulation in vitro (Figure S3), suggesting
that higher IL-2 production in Rictor-deficient CD8 T cells was
programmed regardless of infection with high- or low-affinity
ligand. Enhanced IL-2 production in the absence of functional
mTORC2 was confirmed further in co-transfer experiments (Fig-
ures 3E–3H). Indeed, although, in the WT CD45.1/2+ 1:1 WT
CD45.2+ OT-1 control co-transfer, similar IFNg, TNF-a, and IL-
2 production was apparent upon peptide restimulation in vitro
(Figures 3E and 3G), a significant increase in IL-2 production in
the absence of Rictor was found in the WT CD45.1/2+ 1:1 Rictor
KO CD45.2+ OT-1 transfer settings, whereas IFNg and TNF-a
secretion remained the same (Figures 3F and 3H). These results
indicate that Rictor deficiency works in a CD8 T cell-intrinsic1210 Cell Reports 14, 1206–1217, February 9, 2016 ª2016 The Authorsmanner to selectively increase IL-2 pro-
duction in response to antigen challenge.
Rictor Deficiency Leads to
Enhanced Long-Lived CD8 Memory
T Cell Differentiation
It has been reported that superior IL-2-
producing MPECs differentiate more effi-ciently into long-lived protective memory T cells capable of
self-renewal and rapid recall responses (Joshi et al., 2007; Sar-
kar et al., 2008). Given the enhanced differentiation into high
IL-2-producing MPECs, we investigated whether Rictor defi-
ciency could give rise to increased long-lived memory T cell dif-
ferentiation. We found that the higher levels of KLRG1lo CD127hi
or CD62L+ CD44+ CD8 T cells were maintained stably
throughout the observation time of 4 months post-infection (Fig-
ure 4A). This was also confirmed in the co-transfer setting (Fig-
ures S3B and S3C). Seven weeks after primary infection, we
indeed observed higher frequencies and absolute numbers of
transferred Rictor KO OT-1 cells than of WT OT-1 cells in both
the spleen and pLN, with amore striking increase in pLN (Figures
Figure 5. Rictor Deficiency Alters the Bal-
ance of T-bet and Eomes Expression.
(A) Representative overlay histograms showing
T-bet and Eomes expression on day 7 after
infection.
(B) Representative overlay histograms showing T-
bet and Eomes expression in the mix on transfer
day 7 after infection.
(C and D) As shown in (A), theMFIs of T-bet (C) and
Eomes (D) in the spleen are summarized.
(E) Representative overlay histograms showing
Blimp1 and Bcl-6 expression on day 7 after
infection in the spleen.
(F) The MFI of Blimp1 and Bcl-6 is summarized.
(G) On day 7 after infection, transferred OT-1
effector cells were sorted for real-time PCR anal-
ysis of Id2 and Id3 expression.
Data are representative of three or four indepen-
dent experiments and are presented as themean ±
SEM (4–6 mice/group). *p < 0.05, **p < 0.01.
See also Figure S5.4B and 4C; data not shown). Meanwhile, the absolute numbers
of memory CD8 T cells in non-lymphoid tissues like liver and
lungs were also increased slightly but significantly (Figure 4D).
At this time point, we also confirmed a higher expression level
of CD27, CD62L, and CD127 in the absence of Rictor, whereas
the CD44 expression remained similar (Figure 4E). This
increased CD62L and CD127 expression was still observed
7 months after primary infection (data not shown). Together,
these data support increased memory CD8 T cell generation in
Rictor-deficient T cells.
Rictor KO Memory T Cells Mediate More Potent Recall
Responses
A unique feature of memory T cells is their ability to mediate an
accelerated recall response with higher magnitude upon antigen
re-exposure. To determine the role of mTORC2 in this process,
we transferred similar numbers of WT or Rictor KO memory
CD8 T cells sorted frommice 7weeks after the primary challenge
into naive recipients. The secondary hosts were challenged
1 day later with LM-OVA. On day 4 after infection, we found
significantly increased frequencies and absolute numbers of Ric-
tor KO OT-1 cells in the spleen and liver (data not shown)Cell Reports 14, 1206–1217,compared with WT cell transfer (Figures
4F and 4G), directly implying that Rictor
deficiency increases potently functional
memory CD8 T cells. Interestingly, re-
called Rictor KO OT-1 cells retained
higher CD62L expression. In addition,
they upregulated CXCR3 expression bet-
ter, which is important for homing to
inflammation sites (Figure S4A). Further-
more, we did not observe any difference
in the killing capacity between WT and
Rictor KO secondary effector cells (Fig-
ure 4H). We also assessed cytokine pro-
duction by memory T cells after antigen
re-exposure. Rictor KO secondary effec-tors indeed produced similar amounts of IFNg and TNF-a upon
restimulation (Figures 4I, S4B, and S4C). Together, these results
show that Rictor-deficient memory T cells mount more potent
recall responses while preserving WT-like immediate effector
function.
Enhanced CD8 T Cell Memory Formation in the Absence
of Rictor Is Associated with Transcriptional and
Metabolic Reprogramming
The T box transcription factors T-bet and Eomes control the cell
fate decision between SLECs andMPECs (Intlekofer et al., 2005;
Rao et al., 2012). A higher T-bet/Eomes ratio drives terminal
effector differentiation, whereas a higher Eomes/T-bet ratio fa-
vors memory formation. We therefore examined the expression
pattern of T-bet and Eomes in WT and Rictor KO OT-1 cells on
day 7 after LM-OVA infection. Unexpectedly, given the similar
level of effector cytokine production, we observed a significant
decrease in T-bet expression and concomitantly increased
Eomes expression in Rictor-deficient cells (Figures 5A–5D).
Furthermore, this higher Eomes, lower T-bet expression pattern
in Rictor KO cells was maintained stably even at the contraction
(day 14 after infection; Figures S5A and S5B) or memory phasesFebruary 9, 2016 ª2016 The Authors 1211
Figure 6. Rictor Deficiency Promotes Tcf-1
Expression and Foxo1 Nuclear Accumula-
tion.
(A) Top: representative overlay histograms
showing Tcf-1 expression on day 14 after infection
in the spleen. Bottom: the MFI of Tcf-1 expression
in the spleen is summarized.
(B) Imagestream analysis of Tcf-1 expression on
day 14 after infection. DAPI was used as a coun-
terstain to determine the localization of Tcf-1 in the
nucleus.
(C) Representative overlay histograms showing
pAkt473 (top) and pFoxo1/3a (bottom) expression
4.5 days after infection in the spleen.
(D) Foxo1 localization was determined with
confocal microscopy 4.5 days after LM-OVA N4
infection in the spleen.
Data are representative of two or three indepen-
dent experiments and are presented as the mean
± SEM. **p < 0.01. See also Figure S5.(data not shown). Blimp1 drives terminal differentiation into ef-
fectors cells, whereas Bcl-6 promotes MPEC differentiation (Ji
et al., 2011; Rutishauser et al., 2009). However, we did not
observe any detectable change in Blimp1 and Bcl-6 expression
with Rictor deficiency (Figures 5E and 5F). Id2 and Id3 have been
shown to control CD8 effector and memory differentiation (Ji
et al., 2011; Yang et al., 2011). Consistent with increased mem-
ory formation, we found a slight but significant increase in Id3
expression at the transcription level, whereas Id2 expression re-
mained comparable (Figure 5G).
Tcf-1, the downstream target of the Wnt signaling pathway, is
required for CD8 memory generation and recall response (Jean-
net et al., 2010; Zhou et al., 2010). Consistent with increased
CD8 memory formation in the absence of Rictor, Tcf-1 expres-
sion was enhanced significantly in Rictor KO cells compared
with the WT on day 14 after primary infection in all organs as-
sessed (Figures 6A, 6B, S5C, and S5D). Both the Tcf-1 nuclear
localization pattern and higher expression in the absence of Ric-
tor could be visualized directly at the single-cell level and quan-
tified by Imagestream flow analysis (Figure 6B).1212 Cell Reports 14, 1206–1217, February 9, 2016 ª2016 The AuthorsIn terms of metabolic activity, primed
CD8 T cells switch from oxidative
phosphorylation (OXPHOS) to glycolysis,
whereas CD8 memory T cells, unlike
effector or naive CD8 T cells, exhibit sub-
stantial spare respiratory capacity (SRC)
in their mitochondria (van der Windt
et al., 2012; Waickman and Powell,
2012). IL-15, a crucial cytokine support-
ing CD8 memory T cell generation,
regulates SRC and oxidative metabolism
by promoting carnitine palmitoyl trans-
ferase (CPT1a) expression (van der Windt
et al., 2013). To understand the connec-
tion between CD8 effector or memory
differentiation and metabolic changes
brought about by dysregulated mTORC2signaling, we primed WT or Rictor KO naive OT-1 cells with
SIINFEKL peptide and IL-2 for 3 days and continued to culture
in the presence of IL-2 or IL-15 for another 3-4 days to generate
in vitro ‘‘effector’’ or ‘‘memory’’ cells, respectively. First, we
confirmed the increased SRC with IL-15-treated WT CD8
T cells compared with IL-2 cultured cells (Figures S6A and
S6B). Consistent with enhanced memory differentiation, Ric-
tor-deficient OT-1 cells cultured in IL-15 showed increased
SRC compared with the WT. Interestingly, even when cultured
in the presence of IL-2, which promotes effector differentiation,
Rictor KO cells showed a striking increase in SRC (Figures S6A
and S6B). Memory CD8 T cells preferentially use mitochondrial
fatty acid oxidation (FAO) for their energy supply (Pearce et al.,
2009; van der Windt et al., 2013). By using etomoxir, an inhibitor
of CPT1a, we observed a pronounced decrease in oxygen con-
sumption rate (OCR) (an indicator of OXPHOS) in either WT or
Rictor KO CD8 T cells cultured with IL-15, suggesting that these
memory CD8 T cells highly depend on FAO (Figures S6C and
S6D). In contrast, WT CD8 T cells cultured in IL-2 are less
dependent on FAO to generate energy (Figures S6C and S6D).
Intriguingly, our results showed that, in contrast to WT CD8
T cells, Rictor KO CD8 T cells differentiated under effector con-
ditions rely heavily on CPT1a-dependent fatty acid metabolism
to sustain their OCR, a cardinal metabolic feature of memory
T cells. A higher level of FAO was further confirmed by increased
CPT1a expression in Rictor KO cells (Figure S6G).
To test whether mitochondria were involved in the metabolic
reprogramming by mTORC2 deficiency, we first determined
the mitochondrial mass by using MitoTracker staining for
in vitro-cultured WT and Rictor KO OT-1 cells. Indeed, Rictor
KO OT-1 cells showed increased mitochondrial mass compared
with WT OT-1 cells (Figure S6E). In addition, the ratio of mito-
chondrial DNA versus nuclear DNA was also increased signifi-
cantly in Rictor KO cells (Figure S6F). Ppargc-1a (PGC1a) plays
a key role in mitochondrial biogenesis and function by inducing
the expression of nuclear respiration factor 1 (Nrf-1) and mito-
chondrial transcriptional factor A (Tfam). Consistent with the
increased mitochondrial content, we observed an enhanced
expression of PGC1a, PGC1b, and Tfam in Rictor KO cells (Fig-
ure S6G). Moreover, we found that the expression of several
essential components of the mitochondrial respiratory chain
complex was upregulated (data not shown). Together, these ob-
servations support the fact that Rictor deficiency might promote
memory T cell metabolic features by increasing mitochondrial
function.
Increased Nuclear Foxo1 Accumulation Mediates
Enhanced Memory Formation in Rictor-Deficient CD8 T
Cells
Foxo1 promotes CD8 memory generation by directly control-
ling Eomes and Tcf-1 expression (Hess Michelini et al.,
2013; Kim et al., 2013; Rao et al., 2012; Tejera et al., 2013).
Loss of Foxo1 does not affect CD8 effector responses but
impairs the recall response. Foxo1 is mainly phosphorylated
by Akt or other SGC family kinases. Phosphorylation of
Foxo1 leads to nuclear exit and cytoplasmic localization, re-
sulting in loss of transcriptional activity. Given the enhanced
Eomes and Tcf-1 expression in Rictor KO T cells, we hypoth-
esized higher Foxo1 transcriptional activity through its nuclear
accumulation in the absence of mTORC2 signaling. Therefore,
we determined the levels of pAkt473 and pFoxo1 expression.
Phosphorylation of both Foxo1T24/Foxo3aT32, Foxo1S256
(data not shown), and AktS473 sites were clearly reduced in
Rictor KO T cells on day 5 after LM-OVA infection, as deter-
mined by fluorescence-activated cell sorting (FACS) and west-
ern blotting (Figure 6C; data not shown). In line with this
finding, Foxo1 was mostly localized to the nuclei of Rictor
KO cells, whereas it was mainly cytoplasmic in WT T cells
(Figure 6D).
To further substantiate the role of Foxo1 in transcriptional
reprogramming in Rictor-deficient T cells, we knocked down
Foxo1 with short hairpin RNA (shRNA) and asked whether
reduction of Foxo1 could reverse the increased memory dif-
ferentiation phenotype in the Rictor KO setting. We first
confirmed the efficiency and specificity of the Foxo1 shRNA
(Figure 7A). We then transferred either scramble- or Foxo1
shRNA-transduced Rictor KO OT-1 cells into CD45.1 naive
hosts, followed by LM-OVA infection. Interestingly, Foxo1Cell RshRNA-transduced GFP+ OT-1 cells showed reduced MPEC
differentiation compared with the non-transduced GFP pop-
ulation (Figure 7B). In contrast, the scramble-transduced
population did show MPEC differentiation similar to the un-
transduced internal controls (data not shown). Moreover,
compared with scramble-transduced cells, Foxo1 shRNA-
transduced OT-1 cells indeed produced less IL-2 (Figure 7C).
Together, these results demonstrate that Foxo1 mediates
increased MPEC differentiation and IL-2 production in Ric-
tor-deficient CD8 T cells (Figure 7H). Consistently, Foxo1
knockdown (KD) reduced the expression of CD62L and
CD127 (data not shown). This was also reflected by the upre-
gulation of T-bet but decreased Eomes and Tcf-1 expression
in Foxo1 KD cells (Figures 7D and 7E). More importantly,
silencing of Foxo1 led to an impaired recall response of Rictor
KO memory T cells. Untransduced Rictor memory KO CD8
T cells (GFP) could mediate robust recall response upon re-
challenge. However, memory Rictor KO T cells transduced
with Foxo1 shRNA showed a comparatively largely impaired
re-expansion potential upon antigen rechallenge (Figures 7F
and 7G).
To investigate whether Foxo1 was involved in the metabolic
regulation of CD8 memory formation, we transduced WT OT-1
cells with the Foxo1 AAA mutant, which is constitutively active.
Indeed, we observed the upregulation of CPT1a, a key enzyme
for the b-oxidation of long-chain fatty acids (data not shown).
Importantly, these Foxo1 AAA-transduced WT OT-1 cells show
enhanced SRC-like Rictor KO T cells (Figures S7A and S7B).
Concomitantly, Foxo1 AAA-transduced WT OT-1 cells show
higher FAO because administration of etomoxir largely reduced
the oxygen consumption rate compared with untransduced cells
(GFP). Interestingly, these Foxo1 AAA-transduced cells are
even more dependent on FAO than the Rictor KO cells (Figures
S7C and S7D).
DISCUSSION
In this study, we identify the mTORC2-Akt-Foxo1 signaling axis
as a crucial regulator of CD8 T cell effector andmemory differen-
tiation via specific transcriptional reprogramming.
We show enhanced memory differentiation and better recall
response upon re-challenge by CD8 T cells lacking Rictor. We
further demonstrate that mTORC2 controls CD8 memory T cell
differentiation in a Foxo1-dependent manner. Knocking down
Foxo1 reverses the increasedMPEC differentiation and IL-2 pro-
duction in Rictor KO cells. Foxo1 regulates multiple facets of
T cell biology by controlling proliferation, differentiation, and traf-
ficking. In CD8 T cells, Foxo1 is dispensable for a primary
response upon infection. However, memory formation and recall
response were largely impaired in the absence of Foxo1. In the
absence of mTORC2, increased Foxo1 retention in the nucleus
of CD8 T cells drives enhanced Eomes and Tcf-1 expression,
which promotes CD8memory differentiation (Figure 7H). Indeed,
Foxo1 directly induced expression of both Eomes and Tcf-1, as
shown by chromatin immunoprecipitation sequencing experi-
ments (Hess Michelini et al., 2013; Kim et al., 2013; Rao et al.,
2012; Tejera et al., 2013). Moreover, it is known that Foxo1
acts as a repressor of T-bet expression in CD8 T cells (Raoeports 14, 1206–1217, February 9, 2016 ª2016 The Authors 1213
Figure 7. Rictor Deficiency Promotes CD8
Memory Differentiation in a Foxo1-Depen-
dent Manner
Rictor KOCD45.2OT-1 cells were transducedwith
either scramble or Foxo1-GFP shRNA and then
transferred into naive CD45.1 recipients, followed
by infection.
(A) Representative overlay histograms showing
decreased Foxo1 expression with Foxo1 shRNA
(right) but not with scramble-transduced settings
(left).
(B) The frequencies of cells displaying the
KLRG1loCD127hi phenotype in Rictor KO OT-1
cells transduced with either scrambled or Foxo1
shRNA are summarized.
(C) The frequencies of IFNg+IL-2+-producing cells
upon scramble or Foxo1 shRNA transduction on
day 7 after infection.
(D) Representative overlay histograms showing T-
bet and Eomes expression gated on Foxo1
shRNA-transduced (blue) or non-transduced (red)
Rictor KO OT-1 cells on day 7 after infection.
(E) Representative overlay histograms showing
Tcf-1 expression on scramble (SCR)- or Foxo1
shRNA-transduced cells on day 7 after infection.
(F) 6 weeks after infection, Foxo1 shRNA-trans-
duced or non-transduced memory Rictor KO OT-1
cells were sorted and transferred into a naive host,
followed by re-challenge.
(G) On day 5 after re-challenge, the fold expansion
was calculated on Foxo1 shRNA-transduced or
non-transduced memory cells.
(H) Schematic of mTORC2 in regulating CD8 T cell
memory formation upon infection. Absence of
Rictor leads to decreased Akt473 phosphorylation
upon stimulation and, therefore, phosphorylation
of Foxo1 is decreased. Thus, Foxo1 nuclear
retention drives Tcf1 and Eomes expression,
which promotes CD8 T cell memory differentiation.
Data are representative of two or three indepen-
dent experiments and are presented as themean ±
SEM. **p < 0.01. See also Figures S6 and S7.et al., 2012). Overexpression of Foxo1 inhibits T-bet expression,
whereas Foxo1-deficient CD8 T cells show higher expression of
T-bet (Rao et al., 2012). In line with these observations, we show
much lower expression of T-bet in the absence of functional
mTORC2. Silencing of Foxo1 restores T-bet expression while
reducing Eomes and Tcf1 expression. Interestingly, upon rechal-
lenge, secondary Rictor KO effector cells also show higher
Eomes and lower T-bet expression (data not shown), indicating
a higher possibility of enhanced secondary memory formation.
The involvement of mTORC1 in regulating CD8memory differ-
entiation has been suggested by administration of rapamycin
and metformin (Araki et al., 2009; Pearce et al., 2009). In the
case of rapamycin administration during acute LCMV infection,
the enhanced memory differentiation could be phenocopied by
silencing of Raptor in CD8 T cells (Araki et al., 2009). In marked
contrast, Raptor KO CD8 T cells largely failed to generate effec-
tors and also failed to generate a memory response (L.Z. unpub-1214 Cell Reports 14, 1206–1217, February 9, 2016 ª2016 The Autholished data). This discrepancy suggests that fine-tuning of
mTORC1, but not its ablation, is required for the enhancement
of memory T cell formation. This remains to be addressed exper-
imentally. Alternatively, however, out data raise the possibility
that rapamycin may, in fact, exert its positive effect on memory
T cell formation via the inhibition of mTORC2 signaling in CD8
T cells in addition to inhibiting mTORC1. Such cell type variation
in the ability of rapamycin to inhibit mTORC2 has been shown
recently (Wang et al., 2014).
Interestingly, Rictor KO CD8 T cells produce larger amounts of
IL-2 comparedwith theWT during primary infection. At themem-
ory phase, not only the frequency of IL-2-producing cells but also
the intensity of IL-2 on a per-cell basis are largely increased (data
not shown). These findings are in line with previous reports
showing that autonomous IL-2 production by CD8 T cells during
primary infection was critical for the subsequent mounting of an
effective recall response (Feau et al., 2011; Williams et al., 2006).rs
In this regard, it remains to be addressed whether enhanced IL-2
production during a primary response in Rictor-deficient CD8
T cells accounts for the more potent recall response.
The effector function of Rictor-deficient CD8 T cells remained
largely intact, as also shown in a recent study (Pollizzi et al.,
2015). However, in contrast to that report showing an un-
changed, if not enhanced, frequency of Rictor KO antigen-spe-
cific CD8 T cells, we observed a decreased accumulation of
CD8 effector T cells with Rictor deficiency at the peak of the
response to high- or low-affinity ligand-bearing Listeria. We
discovered that this was mainly due to less sustained prolifera-
tion in the face of comparable apoptosis rates of WT or Rictor
KO effectors. The discrepancy between the two studies may
be due to different infection systems. Pollizzi et al. (2015)
transferred 100-fold more OT-1 cells than we did and used
Vaccinia instead of Listeria infection to convey the OVA antigen.
Another difference is the use of slightly different Rictor-floxed
mice in the two studies. Indeed, the Rictor-floxed mice from
Pollizzi et al. (2015) were exon 3-flanked, whereas ours were
exon 4- and 5-flanked (Bentzinger et al., 2008). Nevertheless,
both Polizzi’s report and our report clearly demonstrate that
effector functions such as cytokine production or killing capacity
are unchanged upon Rictor deficiency, whereas enhanced
memory responses can be induced.
It has become clear that CD8 T cell effector or memory differ-
entiation processes are coupled with metabolic reprogramming.
Unlike naive or effector T cells, memory CD8 T cells show higher
SRC. In our study, we show that mTORC2-deficient CD8 T cells
show increased SRC and FAO even in the presence of IL-2, indi-
cating that metabolic reprogramming prevails even under condi-
tions conducive to effector cell T cell differentiation, such as
supplementation with IL-2 in activated T cell culture medium.
We believe that the enhanced SRC and FAO in Rictor-deficient
T cells were, at least in part, due to decreased Akt activity caused
by mTORC2 functional deficiency. Indeed, we observed that a
short period of Akt inhibition in vitro during CD8 T cell priming
leads to enhanced generation of T cells with the memory pheno-
type (data not shown). More importantly, these Akt inhibitor
pre-treated CD8 T cells show increased SRC and FAO, as deter-
mined by Seahorse analysis. Interestingly, we observed a
significant increase in CPT1a expression in either Rictor KO
CD8 T cells or WT CD8 T cells cultured in the presence of Akt in-
hibitor. Clearly, further exploration of mitochondrial function in
mTORC2-deficient CD8 T cell differentiation is warranted.
SGK1 represents another key target downstream of mTORC2
signaling. Recently, SGK1 has been shown to promote Th2 dif-
ferentiation (Heikamp et al., 2014). However, the role of SGK1
in CD8 T cells is unclear. Therefore, it remains important to
address the possibility of SGK1 involvement in the regulation
of transcriptional activity of Foxo1 and in CD8 memory forma-
tion. Foxo1 is a transcription factor that regulates genes control-
ling multiple cellular processes, including metabolism. However,
Foxo1 activity seems to be tightly regulated by the exact amount
of nuclear Foxo1, the availability of its co-activators/repressors,
and post-translational modifications. It is conceivable that there
might be differential requirements for Foxo1 during memory
T cell differentiation and maintenance, important aspects that
require further scrutiny.Cell RInhibition ofmTORC1 or Akt correlates with increasedmemory
formation and long-term persistence in vivo and enhanced tumor
protection effects (Araki et al., 2009; Crompton et al., 2015; Kim
et al., 2012; Pearce et al., 2009). We identified mTORC2 as a
critical regulator of CD8memory formation by orchestrating tran-
scriptional and metabolic programming. mTORC2 signaling has
typically been associated with control of cytoskeleton organiza-
tion and cell adhesion and motility. These aspects need to be
probed in responding Rictor-deficient CD8 T cells. In CD8
T cells, however, its role as a repressor of Foxo1 transcriptional
activity suggests that the level of mTORC2 signaling in activated
T cells has a direct effect on their ability to undertake thememory
T cell differentiation pathway. Together, our findings raise the
possibility that therapeutic inhibition of mTORC2 represents an
effective strategy to generate robust memory responses against
infections and cancer and but preserve potent effector functions.
EXPERIMENTAL PROCEDURES
Animals
Rictorflox/flox mice have been described previously (Bentzinger et al., 2008).
T cell-specific Rictor KO mice were obtained by crossing Rictorflox/flox mice
with transgenic mice that carried CD4 promoter-mediated Cre recombinase.
All mouse strains were backcrossed to the C57BL/6J background. Rictor
KO mice were further crossed on the OT-1 background. CD45.1 congenic
C57BL/6 mice and CD45.1/2 WT OT-1 mice were maintained at the University
of Lausanne’s specific pathogen-free facility. This study was approved by the
veterinary authority of the Canton Vaud (Permit 2688.0), and all experiments
were performed in accordance with Swiss ethical guidelines.
OT-1 Cell Transfer and LM-OVA Infection
Naive OT-1 cells were purified with a naive CD8 isolation kit (STEMCELL Tech-
nologies). 10,000 CD45.2 naive WT or Rictor KO OT-1 cells were then trans-
ferred into the naive CD45.1 host intravenously (i.v.). For co-transfer settings,
10,000 CD45.1/2WT naive OT-1 cells weremixed at a 1:1 ratio with naive OT-1
cells either fromCD45.2 Rictor KOmice or CD45.2WT littermates. Within 24 hr
after OT-1 cell transfer, 2000 colony-forming units (CFUs) of LM-OVA N4 or T4
variants were administered i.v.
More experimental procedures can be found in the Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.12.095.
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